BIRC5 and endometrial cancer: Another study has also shown that the presence of an aAb to topoisomerase I, as detected by ELISA in the absence of survivin-expressing cancer cells (in the peripheral blood), is associated with longer survival in endometrial cancer as compared to patients without aAbs but with survivin-positive cancer cells in the peripheral blood [112].